Review
doi: 10.1111/j.1365-2141.2007.06641.x.
A strategic framework for novel drug development in multiple myeloma
Affiliations
- PMID: 17593022
- DOI: 10.1111/j.1365-2141.2007.06641.x
Item in Clipboard
Review
A strategic framework for novel drug development in multiple myeloma
Br J Haematol.
2007 Jul.
No abstract available
Similar articles
-
[Methodological approaches of clinical studies with targeted therapies].Bull Cancer. 2008 Feb;95(2):185-90. doi: 10.1684/bdc.2008.0575. Bull Cancer. 2008. PMID: 18304903 Review. French.
-
Developing drugs that do not cause tumor regression.Clin Adv Hematol Oncol. 2003 Nov;1(11):654-5. Clin Adv Hematol Oncol. 2003. PMID: 16258462 No abstract available.
-
Randomized phase II trials: misleading and unreliable.J Clin Oncol. 2010 Nov 1;28(31):e649-50; author reply e651-3. doi: 10.1200/JCO.2010.31.3254. Epub 2010 Sep 20. J Clin Oncol. 2010. PMID: 20855829 No abstract available.
-
Clinical trials.Methods Mol Med. 2003;87:335-52. doi: 10.1385/1-59259-399-2:335. Methods Mol Med. 2003. PMID: 12958466 No abstract available.
-
Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.Cancer Invest. 2008 Jun;26(5):439-44. doi: 10.1080/07357900801971057. Cancer Invest. 2008. PMID: 18568764 Review. No abstract available.
Cited by
-
IL-6 and MYC collaborate in plasma cell tumor formation in mice.Blood. 2010 Mar 4;115(9):1746-54. doi: 10.1182/blood-2009-08-237941. Epub 2009 Dec 17. Blood. 2010. PMID: 20018915 Free PMC article.
-
Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.J Pathol. 2010 Jul;221(3):242-7. doi: 10.1002/path.2714. J Pathol. 2010. PMID: 20527018 Free PMC article.
-
A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.Br J Cancer. 2013 Mar 19;108(5):1061-70. doi: 10.1038/bjc.2013.74. Epub 2013 Feb 28. Br J Cancer. 2013. PMID: 23449360 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
